Kathmandu. Nawalparasi District Gaidakot Municipality Ward No. The Nepal Stock Exchange (NEPSE) has decided to issue a face value of Rs 100,000 per share to be issued by the corporate entity subject to the prevailing laws relating to securities. Securities Board of Nepal (SEBON) dated 2078 for eligible institutional investors through the method of 100 units of Ordinary Share Book Building Method. 01. Nepal Stock Exchange Limited and Time Pharmaceuticals Limited have signed a sealed bidding agreement in accordance with the Clause 18 of the Book Building Directive, 2077 (2077/78) and the clause 5 (2) of the Book Building Directive, 2077 (2077/78) and the sealed bidding agreement for the registration of the sealed bid as per the Book Building Directive, NEPSE will facilitate the opening of the tender and other conditions ।
The agreement was signed by Mr. Chudamani Chapagain, Chief Executive Officer of NEPSE and Mr. Sudarshan Lal Shrestha, Managing Director of Time Pharmaceuticals. Similarly, Mr. Sudip Ghimire, Company Secretary and Mr. Manohar Kandel on behalf of Nabil Investment were also present on behalf of the company.
Time Pharmaceuticals Ltd. The company is set to issue 10,86,500 units of ordinary shares worth Rs 10,86,50,000 (Rs 10,86,50,000 only) through the ordinary share book building method. Out of the offered shares, 40% of the shares will be issued to the eligible institutional investors and the remaining 60% will be issued to the general public. After the issuance of the shares, the paid-up capital of the company will be Rs. 5,300,00,000. It will be 00 (only fifty-three crores).
Time Pharmaceuticals Limited has been producing more than 200 quality medicines for the last 30 years by establishing a central office at Gaindakot Municipality Ward No. 04, a production plant (industry) at Gaindakot Municipality Ward No. 10 and a marketing office at Satdobato, Lalitpur by providing direct employment to about 300 employees.
